rs35092519
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_032119.4(ADGRV1):c.12927G>A(p.Ala4309=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.025 in 1,613,416 control chromosomes in the GnomAD database, including 690 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A4309A) has been classified as Likely benign.
Frequency
Consequence
NM_032119.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.12927G>A | p.Ala4309= | synonymous_variant | 64/90 | ENST00000405460.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.12927G>A | p.Ala4309= | synonymous_variant | 64/90 | 1 | NM_032119.4 | P1 | |
ADGRV1 | ENST00000425867.3 | c.1881G>A | p.Ala627= | synonymous_variant | 12/38 | 5 | |||
ADGRV1 | ENST00000640464.1 | n.3346G>A | non_coding_transcript_exon_variant | 21/21 | 5 | ||||
ADGRV1 | ENST00000639431.1 | c.265+102733G>A | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0351 AC: 5343AN: 152078Hom.: 124 Cov.: 32
GnomAD3 exomes AF: 0.0239 AC: 5948AN: 248854Hom.: 118 AF XY: 0.0231 AC XY: 3114AN XY: 134986
GnomAD4 exome AF: 0.0239 AC: 34922AN: 1461220Hom.: 567 Cov.: 31 AF XY: 0.0235 AC XY: 17106AN XY: 726902
GnomAD4 genome ? AF: 0.0352 AC: 5351AN: 152196Hom.: 123 Cov.: 32 AF XY: 0.0341 AC XY: 2535AN XY: 74426
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 23, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 16, 2010 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 14, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Usher syndrome type 2C Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at